Rx for Merck?

The biggest drag on the blue chip Dow stocks on 10/28/13 was Merck. Shares of the drug maker fell 2.5 percent after reporting profits fell by a third last quarter.

Bertha Coombs reports on the challenges that Merck has been facing and what it`s doing to cut costs and boost sales in the future.

This entry was posted in Health Care, NBR Show Clips. Bookmark the permalink.

Leave a Reply